" class="no-js "lang="en-US"> Denali Therapeutics - Medtech Alert
Tuesday, July 29, 2025
Denali Therapeutics | Pharmtech Focus

Denali Therapeutics

About Denali Therapeutics

Denali Therapeutics

Denali Therapeutics is dedicated to defeating neurodegenerative diseases by breaking through historical barriers in scientific research and clinical development in order to deliver safe and effective medicines to patients and families. Our scientific approach is based on three core principles: rigorous assessment of genetic targets, engineering brain delivery, and using biomarkers to guide development. Our team thrives in a work environment that is scientifically driven, impact-focused, supportive, and collaborative. Our ability to have a positive impact on people’s lives is directly related to the trust we have in each other and our ability to unify our diverse backgrounds and experience behind our purpose to defeat degeneration.

Related Story

PharmEnable Announces Multi-target Collaboration With Denali Therapeutics in Neurodegenerative Disease

May 30 2022

PharmEnable, an AI drug-discovery company mapping unexplored chemical space to deliver innovative medicines, has announced […]